The analysis of global skin and subcutaneous tissue diseases mortality in 2023 revealed significant disparities across countries. Brazil reports the highest mortality among the examined countries, with a notable increase from last year's data. The United States and Mexico also show substantial numbers, albeit with a declining trend in the US. Poland and Portugal experienced significant year-on-year increases, whereas some European countries like Iceland and Estonia reported large fluctuations despite lower absolute values. Countries like Switzerland and Slovenia have the lowest mortality rates, with Slovenia showing a significant decrease in 2023.
Future trends to watch include technological and treatment advancements in dermatology, potential impacts of healthcare policies, and an increase in preventive measures. Notably, countries with increasing mortality rates might benefit from targeted interventions. Monitoring the effects of environmental changes on skin and subcutaneous tissue diseases will also be crucial in future analyses.
Top countries in Skin and Subcutaneous Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Brazil | 4,410 | 2023 | +3.86% | +4.75% | View data |
| 2 | 2 United States | 3,250 | 2023 | +1.18% | +2.27% | View data |
| 3 | 3 Mexico | 2,630 | 2023 | +11.1% | +4.92% | View data |
| 4 | 4 Argentina | 1,950 | 2023 | +6.17% | +3.31% | View data |
| 5 | 5 Japan | 1,870 | 2023 | +2.81% | +3.03% | View data |
| 6 | 6 United Kingdom | 1,470 | 2023 | +1.1% | +0.81% | View data |
| 7 | 7 Spain | 1,350 | 2023 | +2.44% | +2.55% | View data |
| 8 | 8 Germany | 1,050 | 2023 | +0.67% | +1.02% | View data |
| 9 | 9 South Africa | 982 | 2023 | +2.19% | +1.85% | View data |
| 10 | 10 Colombia | 814 | 2023 | +0.99% | +3.66% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...